/
/
Full Podcast Episode: Attacking AML Cells with a New Immunotherapy Infusion with Dr. Kendra Sweet
Full Podcast Episode: Attacking AML Cells with a New Immunotherapy Infusion with Dr. Kendra Sweet image
Full Podcast Episode: Attacking AML Cells with a New Immunotherapy Infusion with Dr. Kendra Sweet
Posted Jun 09, 2022

To stay up to date about upcoming podcasts and events, join our Facebook groups:

ADULT AML

AML CAREGIVERS

HealthTree Podcast for AML Episode

Kendra Sweet, MD
Moffitt Cancer Center
Interview Date: June 9, 2022

Thanks to Our Episode Sponsor

Show Summary

Immunotherapy continues to be an expanding and evolving area of research for AML with many drugs in development. In this show, Dr. Kendra Sweet, an AML expert from Moffitt Cancer Center, shared with us about an antibody drug conjugate called IMGN632 and the current trials using this drug.  IMGN632 targets CD123-positive AML cells and has shown promising results in relapsed/refractory patients in previous AML trials. 

Listen to the Full Show:

*Full Show Transcript Coming Soon*

Join the HealthTree Podcast for AML Chapter to receive emails on upcoming episodes:

SIGN UP HERE

The author Kerith Amen

about the author
Kerith Amen

Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.

More HealthTree Podcast for AML Articles

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811